CLIA COVID-19 NP

Chemiluminescence kit for the determination of IgG, IgA or IgM antibodies against SARS-CoV-2 virus nucleocapsid protein (COVID-19) in human serum or plasma.

Coronaviruses belong to the family of enveloped RNA viruses. In humans, they cause diverse clinical pictures, from the common cold to severe respiratory syndromes (MERS, SARS, and COVID-19). SARS-CoV-2, the cause of COVID-19, is a respiratory virus discovered in 2019. It is primarily transmitted to an individual through close contact with an infected person, during which infectious droplets spread to the environment. Symptoms of COVID-19 are highly variable, ranging from none to life-threatening illness.

The SARS-CoV-2 virus contains four structural proteins: spike (S), nucleocapsid (N), envelope (E), and membrane (M) protein. Responding to the infection, the human immune system raises specific antibodies, starting with IgA and IgM. The IgG antibodies represent a later matured response. Serological tests play only a supporting role in COVID-19 diagnosis. However, they are effective in assessing the immune response of an individuum or population.

Nucleocapsid protein (NP) encapsulates viral genomic RNA and forms a major component of the viral structure. NP is a highly antigenic epitope, which is highly conserved and does not change when the virus is mutated. In patients who have had COVID-19 infection, the anti-NP antibodies are usually measured at higher levels than antibodies to other SARS-CoV-2 proteins.

Products

100 Tests
Article no.: 71001 Request
100 Tests
Article no.: 71003 Request
100 Tests
Article no.: 71002 Request

Advantages

  • Detection of IgG, IgA or IgM antibodies against the nucleocapsid protein (NP) of SARS-CoV-2.
  • Determined for human serum and plasma
  • Recombinant nucleocapsid antigen (rNP) used.
  • Kits are CE-IVD certified and intended for professional use 
  • For each CLIA kit a corresponding control set is available
Assay time 40 min
Assay stability 30 days in-board-stability / in-use-stability until the expiration date at storage temperature 2-8 °C
Sample matrix Serum, Plasma
Sample volume 10 µL
Sample stability 7 days at 2-8 °C, 24 months at -20 °C
Measuring range 5-320 U/ml (IgG), 5-100 U/ml (IgA and IgM)
Assay/kit content Reagent Cartridge with specific reagents for the assay, magnetic particles, calibrators